Anthony B Evnin - Net Worth and Insider Trading

Anthony B Evnin Net Worth

The estimated net worth of Anthony B Evnin is at least $202 Million dollars as of 2024-11-29. Anthony B Evnin is the Director of Constellation Pharmaceuticals Inc and owns about 5,742,765 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $195 Million. Anthony B Evnin is the Director of Juno Therapeutics Inc and owns about 66,301 shares of Juno Therapeutics Inc (JUNO) stock worth over $6 Million. Anthony B Evnin is also the Director of Cantel Medical Corp and owns about 10,197 shares of Cantel Medical Corp (CMD) stock worth over $819,533. Besides these, Anthony B Evnin also holds AVEO Pharmaceuticals Inc (AVEO) , Infinity Pharmaceuticals Inc (INFIQ) . Details can be seen in Anthony B Evnin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony B Evnin has not made any transactions after 2020-03-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anthony B Evnin

To

Anthony B Evnin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony B Evnin owns 9 companies in total, including Cantel Medical Corp (CMD) , Infinity Pharmaceuticals Inc (INFIQ) , and AVEO Pharmaceuticals Inc (AVEO) among others .

Click here to see the complete history of Anthony B Evnin’s form 4 insider trades.

Insider Ownership Summary of Anthony B Evnin

Ticker Comapny Transaction Date Type of Owner
CMD Cantel Medical Corp 2020-07-31 director
INFIQ Infinity Pharmaceuticals Inc 2015-09-01 director
AVEO AVEO Pharmaceuticals Inc 2018-11-21 director
LIMIT LIMIT 2019-12-13 director
LIMIT LIMIT 2018-03-05 director
LIMIT LIMIT 2013-12-05 director
LIMIT LIMIT 2012-07-02 director & 10 percent owner
LIMIT LIMIT 2009-04-03 director
LIMIT LIMIT 2005-09-27 director

Anthony B Evnin Latest Holdings Summary

Anthony B Evnin currently owns a total of 5 stocks. Among these stocks, Anthony B Evnin owns 5,742,765 shares of Constellation Pharmaceuticals Inc (CNST) as of December 13, 2019, with a value of $195 Million and a weighting of 96.44%. Anthony B Evnin owns 66,301 shares of Juno Therapeutics Inc (JUNO) as of June 20, 2017, with a value of $6 Million and a weighting of 2.85%. Anthony B Evnin also owns 10,197 shares of Cantel Medical Corp (CMD) as of March 26, 2020, with a value of $819,533 and a weighting of 0.4%. The other 2 stocks AVEO Pharmaceuticals Inc (AVEO) , Infinity Pharmaceuticals Inc (INFIQ) have a combined weighting of 0.31% among all his current holdings.

Latest Holdings of Anthony B Evnin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNST Constellation Pharmaceuticals Inc 2019-12-13 5,742,765 33.99 195,196,582
JUNO Juno Therapeutics Inc 2017-06-20 66,301 86.96 5,765,535
CMD Cantel Medical Corp 2020-03-26 10,197 80.37 819,533
AVEO AVEO Pharmaceuticals Inc 2018-11-21 41,852 15.00 627,780
INFIQ Infinity Pharmaceuticals Inc 2014-09-30 67,400 0.00 7

Holding Weightings of Anthony B Evnin


Anthony B Evnin Form 4 Trading Tracker

According to the SEC Form 4 filings, Anthony B Evnin has made a total of 1 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Constellation Pharmaceuticals Inc is the acquisition of 400,000 shares on December 13, 2019, which cost Anthony B Evnin around $14 Million.

According to the SEC Form 4 filings, Anthony B Evnin has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the acquisition of 9,000 shares on June 20, 2017, which cost Anthony B Evnin around $219,600.

According to the SEC Form 4 filings, Anthony B Evnin has made a total of 1 transactions in Cantel Medical Corp (CMD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cantel Medical Corp is the acquisition of 2,500 shares on March 26, 2020, which cost Anthony B Evnin around $97,075.

More details on Anthony B Evnin's insider transactions can be found in the Insider Trading History of Anthony B Evnin table.

Insider Trading History of Anthony B Evnin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anthony B Evnin Trading Performance

GuruFocus tracks the stock performance after each of Anthony B Evnin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony B Evnin is 41.08%. GuruFocus also compares Anthony B Evnin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony B Evnin within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anthony B Evnin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anthony B Evnin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
5 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.86 LIMIT LIMIT LIMIT LIMIT LIMIT

Anthony B Evnin Ownership Network

Ownership Network List of Anthony B Evnin

No Data

Ownership Network Relation of Anthony B Evnin

Insider Network Chart

Anthony B Evnin Owned Company Details

What does Cantel Medical Corp do?

Who are the key executives at Cantel Medical Corp?

Anthony B Evnin is the director of Cantel Medical Corp. Other key executives at Cantel Medical Corp include director & 10 percent owner & Chairman Charles M Diker , director & Chief Executive Officer George L Fotiades , and Executive Vice President Seth M Yellin .

Cantel Medical Corp (CMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cantel Medical Corp (CMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cantel Medical Corp (CMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cantel Medical Corp (CMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cantel Medical Corp Insider Transactions

No Available Data

Anthony B Evnin Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony B Evnin. You might contact Anthony B Evnin via mailing address: C/o Venrock Associates, 7 Bryant Park, 23rd Floor, New York Ny 10018.

Discussions on Anthony B Evnin

No discussions yet.